SCHEMBL27956166

SCHEMBL27956166

O=C(O)Cc1ncc(Br)cc1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AGBL2 Q5U5Z8 2/20 0.44
PLAU P00749 1/20 0.41
MEN1 O00255 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
KMT2A Q03164 1/20 0.40
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
THRB P10828 1/20 0.37
AKR1B1 P15121 2/20 0.36
CA2 P00918 1/20 0.36
P4HTM Q9NXG6 1/20 0.36
GABRR1 P24046 1/20 0.36
GLA P06280 1/20 0.36
POLB P06746 1/20 0.35
HCAR2 Q8TDS4 1/20 0.35
PTGDR2 Q9Y5Y4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29354953 0.81 LMNA (0.51) AGBL2PLAUAKR1B1CA2GABRR1
SCHEMBL940173 0.81 LMNA (0.51) AGBL2PLAUAKR1B1CA2GABRR1
SCHEMBL18335081 0.80 LMNA (0.41) PLAUMEN1CYP1A2CYP3A4CYP2D6
SCHEMBL27956188 0.79 AGBL2 (0.44) AGBL2CYP1A2KMT2AKDM4EALDH1A1
SCHEMBL1256353 0.79 AGBL2 (0.51) AGBL2MEN1CYP1A2CYP2C9KMT2A
SCHEMBL16793840 0.78 NPC1 (0.39) PLAUMEN1CYP1A2CYP3A4CYP2D6
SCHEMBL30499537 0.78 DPP4 (0.42) MEN1CYP1A2CYP3A4CYP2D6CYP2C9
Hydrochloric Acid SCHEMBL28487392 0.77 AGBL2 (0.63) AGBL2MEN1CYP1A2CYP2D6KMT2A
SCHEMBL1577363 0.77 PLAU (0.50) PLAUMEN1CYP1A2CYP3A4CYP2D6
SCHEMBL27956182 0.76 AGBL2 (0.45) AGBL2MEN1CYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103906748-A 2-amino-4-(pyridin-2-yl)-5, 6-dihydro-4H-1, 3-oxazine derivatives and their use as BACE-1 and/or BACE-2 inhibitors NOVARTIS AG 2014-07-02 CN disclosed